genet factor associ progress geograph atrophi lesion agerel macular degener felix monika emili tobia steffen arno michael rinki anand frank bernhard institut human regensburg regensburg ophthalmolog bonn bonn nation eye institut nation institut bethesda unit state macular degener casey eye institut oregon dever eye institut portland oregon unit state bweb klinik uniregensburg worldwid agerel macular degener amd serious threat vision loss dividu year age pool preval approxim number peopl afflict condit estim reach million amd lesion present geograph atrophi show high interindividu variabl lit tle prognost factor aim elucid contribut clini cal demograph genet factor progress analys current largest dataset lesion growth find signific independ contribut factor lesion growth includ genet factor well clini cal compon presenc fellow eye correl joint explain interindividu varianc lesion progress consid strategi plan intervent trial aim evalu option advanc amd introduct agerel macular degener amd common caus blind western societi estim preval form diseas reach almost preval rate higher european asian african wellfound estim project worldwid number peopl amd million million futur dramat individu well socioeconom burden diseas amd success stage earli intermedi final late form atroph neovascular subtyp distinguish earli form open citat grassmann fleckenstein chew strunz schmitzvalckenberg bel genet factor associ progress geograph atrophi lesion age relat macular degener plos pone academ neena haider schepen eye institut massachusett eye ear ophthalmolog harvard bostonn unit state publish copyright open free copyright freeli reproduc distribut transmit modifi built otherwis use anyon law purpos made creativ common domain dedic data avail statement relev data within paper support inform file fund support part deutsch forschungsgemeinschaft bhfw alcon institut bhfw eyc intramur programmem nation eye institut eyc grant nation eye institut nation institut bethesda mlk funder role design data plos pone collect decis publish prepar compet interest member advisori board novarti pharma gmbh genentech inc consult receipt speaker fee heidelberg engin gmbh novarti pharma gmbh bayer healthcar pharmaceut grant genentech inc heidelberg engin gmbh opto gmbh zeiss deutschland patent ssv consult novarti pharma gmbh honouraria lectur heidelberg engin gmbh novarti pharma gmbh opto gmbh grant allergan inc genentech inc heidelberg engin gmbh novarti pharma gmbh opto gmbh hoffmannla roch topcon gmbh zeiss deutschland apg consult novarti pharma gmbh grant heidelberg engin gmbh opto gmbh zeiss deutschland royalti michigan amdrel patent uspto fgh consult advisori board member heidelberg engin gmbh grant heidelberg engin gmbh opto gmbh zeiss deutschland speaker fee heidelberg engin gmbh opto gmbh bhfw consult alcon pharma genentech inc advisori board member novarti pharma allergan inc alter author adher plos polici share data materi eyc mlk compet financi interest declar progress geograph atrophi lesion amd characteris abnorm level retin pigment epithelium rpe deposi tion extracellular materi locat predomin bruch membran rpe materi accumul becom recognis clinic individu drusen depo drusen size greater micron diametr design larg drusen eye classifi intermedi amd drusen becom fluent associ rpe hyper hypopigment presenc larg drusen strong indic increas risk develop late form diseas mani fest geograph atrophi involv gradual degener disappear rpe photoreceptor cell choriocapillari layer choroid central retina form late stage manifest exud neovascular phenotyp accompa nie choroid neovascularis cnv subpigmentepitheli subretin intraretin extracellular fluid accumul evolv retin scar untreat late stage diseas manifest exist eye mix neovascular amd eye fellow eye cnv asso ciat function impair typic progress slowli eventu extend beyond macular area retina intravitr administr antiva cular endotheli growth agent benefici neovascular amd proven therapi proport late stage amd approxim incid neovascular form occur common individu year age emphasis age popul underscor effect prevent slow cure diseas lesion usual expand averag growth rate ultim result sever central vision loss metaanalysi nomewid associ advanc stage amd identifi loci biolog pathway under amd slowli get recognis limit inform influenc genet demograph factor growth report signific contribut common amd risk associ haplotyp locus progress measur lesion size correl replic sampl size inconsist ascrib number specif respect relat imag colour fundus photograph fundus autofluoresc correct initi lesion size differ summar obtain growth rate pres enc fellow eye signific modul growth design evalu stateoftheart trial requir factor contribut progress atroph lesion valid find identifi factor correl lesion growth analys current largest dataset lesion growth combin fundus auto fluoresc agerel macular degener fam multicentr duct agerel eye diseas are conduct unit state valid earlier find variant presenc bilater expand search genet mograph factor correl lesion growth data provid evi denc signific correl lesion growth presenc fellow eye respect correl depend joint explain interindividu vari anc growth plos pone progress geograph atrophi lesion amd characterist particip popul fam discoveri fam replic are replic imag number individu followup year interv examin year number examin age year growth growth patient bilater initi size fraction male growth faf faf colour fundus combin mix faf fundus auto uoresc pone materi method ethic statement follow tenet declar helsinki approv local eth board bonn nih irb oper irb panel inform written consent obtain patient explan consequ characterist characterist summaris screen fam discoveri initi valid fam replic includ total eye patient fundus autofluoresc agerel macular degener fam clinicaltri gov valid find are replic clude eye patient agerel eye diseas are classif geograph atrophi famstudi eye central within radius foveal central includ classifi eye general funduscop defin wellcircumscrib usual circular patch partial depigment rpe typic exposur under larg choroid blood vessel amd defin sharpli demarc lesion clear reduc faf extend approxim diametr correspond exud retin chang bleed exud fibrous scar eye funduscop visibl soft drusen retin pigment abnorm consist amd are associ amd defin stereoscop colour fundus photograph sharpli circumscrib area rpe depigment occur macular area general consid circular shape obvious visualis under choroid blood vessel size must larg disc diametr area rpe atrophi within adjac fibrosi featur neovascular consid plos pone progress geograph atrophi lesion amd central defin involv fovea determin retin vascular configur pigment chang digitis imag evalu area use computeris planimetri fundus autofluoresc faf measur calcul growth rate fam faf measur lesion area determin previous port are analys area colour fundus photograph elimi nate depend growth rate baselin lesion size measur individu area measur squar root transform area calcul lesion growth examin interv divid root transform area examina tion point year yield linear growth rate lesion case growth rate measur imprecis growth rate interv set zero result growth rate examin interv summaris individu comput growth rate individu data eye patient comput growth rate eye individu use generat normal distribut data reduc bias outlier growth rate individu log transform natur logarithm result singl logsquareroot growth rate variabl individu growth use analys growth demograph variabl age examin year gender lesion size eye unilater eye bilater last examin well followup tient interv examin year record addi tional report number examin individu minimum maxeimum order confound number examin growth genotyp genet risk score grs genotyp perform briefli genom dna extract ripher blood leukocyt establish method genotyp perform taqman snp genotyp foster citi pcr follow restrict enzym digest england biolab ipswich restrict fragment rflp result genotyp code number amd risk increas lele allel case control variant use comput genet risk score grassmann weight obtain parsimoni model base snps statist analys visualis visualis raw data comput confid interv growth rate differ subgroup use ggplot function packag draw jitterplot linear regress done evalu correl netic variabl growth comput pvalu confid interv impl ment furthermor obtain pvalu adjust conserv bonferroni correct multipli pvalu number independ test perform sinc conduct stage setup subsequ combin obtain slope plos pone progress geograph atrophi lesion amd standard error independ use function rma packag metafor conduct metaanalysi assum random effect model allow assess heterogen estim result design investig demograph variabl well ten genet factor lesion growth eye individu stage design area measur root transform elimin depend growth rate initi lesion size singl growth rate individu calcul take calcul growth rate individu step aim replic find earlier risk haplotyp locus show risk increas allel increas lesion growth rate search signific correl growth genet factor discoveri includ random select individu fam discoveri consid factor show nomin signific cor relat praw replic signific find replic addit fam replic are replic individu metaanalysi conduct size standard error vidual assum random effect model final pvalu adjust conserva bonferroni correct assum independ statist test correct pvalu pcorrect consid signific last fit multivari linear regr sion model evalu independ signific correl factor influenc risk allel growth klein signific contribut risk allel lesion growth individu are expand analys calcul correl number risk allel variant growth extend are panel patient nomin signific correl slope consist find ing replic fam fam discoveri fam replic tain slope standard error pool use random effect model combin slope raw pvalu correl remain statist signific correct multipl test pcorrect evid heterogen phet correl visualis combin stratifi patient accord ing genotyp homozyg nonrisk heterozyg risk homozyg risk plot growth rate individu correl genet factor growth estim contribut addit genet factor lesion growth genotyp common amd associ variant loci fam discoveri frequenc variant fam discoveri compar amd case signific independ influ enc risk amd addit calcul genet risk score grs summaris genet risk individu particip averag grs discoveri plos pone progress geograph atrophi lesion amd plos pone progress geograph atrophi lesion amd forestplot represent univari linear regress model univari linear regress model fit variabl bilater separ slope standard error obtain model combin perform metaanalysi assum random effect model combin estim slope confid interv comput random effect model analys evid heterogen pheterogen pone slight higher valu patient discoveri neither genet risk score singl genet variant ana lyze reveal signific influenc growth rate praw excep tion variant praw interest risk increas allel reduc growth rate slope individu increas risk develop amd risk increas allel show reduc rate lesion growth compar individu carri risk increas allel valid find replic correl fam replic are replic slope repli cation cohort pool find mix effect model random effect model slope demonstr high signific cor relat number risk allel growth praw remain statist signific adjust multipl test pcorrect dition signific evid heterogen phet correl demograph factor growth root transform measur area prior calcul growth rate signifi correl initi lesion size root transform initi lesion size growth rate lesion signific correl gender age number examin determin growth rate strong correl presenc fellow eye bilater growth agreement report find indic signific growth case eye individu slope regress model estim discoveri valid find bilater investigat replic cohort replic size direct discoveri find summaris meta slope standard error obtain individu random effect model show high signific correl slope presenc bilater growth praw remain signific plos pone progress geograph atrophi lesion amd lesion growth rate individu combin measur area squareroot transform transform area growth rate calcul growth rate individu obtain calcul growth rate individu eye affect eye calcul result singl growth variabl individu individu growth rate transform natur logarithm stratifi genotyp genotyp presenc absenc bilater pone adjust multipl test pcorrect signific evid heterogen phet growth rate individ ual stratifi presenc absenc bilater visualis jitterplot multivari linear regress model correl risk allel presenc bilater sion growth identif genet variant univari gression evalu possibl factor influenc confound correl factor fit multivari linear gression model combin iden tifi factor model signific evid confound factor correl factor pcorrect adjust multivari linear regress factor signific correl growth fam discoveri fam replic are replic combin bilater valu linear regress model null model combin size estim random effect model metaanalysi pone plos pone progress geograph atrophi lesion amd slope multivari analys differ averag later compar slope univari combin regress model show high signific fit praw adjust plain variat growth rate aim elucid contribut genet well demo graphic factor rate amd lesion enlarg extend effort provid data largest dataset lesion progress far eye affect includ eye random pool data eye chose growth rate serv eye individu singl variabl assumpt germ genet variant influenc lesion growth fashion eye inde other report high degre concord growth rate affect eye patient note are reveal lower occur renc bilater explain main find first ascertain strategi differ are fam are specif recruit tient unilater late stage amd baselin fam protocol includ uni bilater patient second signific lower age are compar fam individu unilater like prog ress advanc stage fellow eye individu without late amd manifest expect number bilater case are number earlier report signific influenc genet factor lesion growth adjust multipl test nevertheless correl present report suggest base subsampl patient cohort correl statist signific adjust ple test furthermor fam sever eye exclud current anali sis exhibit faf phenotyp reminisc monogenet diseas gpsfaf pattern cacdfaf phenotyp addit note usual account larg influenc initi size lesion rate progress possibl confound analys root transform measur area eliminat furthermor includ twice number ticip singl higher power detect signific correl data signific correl lesion size number risk lele variant repres amd risk haplotyp locus function locus yet identifi inappropri specul mechan involv locus tribut well progress diseas locus risk increas allel reduc growth rate sion risk increas allel result reduc level cfh bind over activ complement statist correl lesion size risk variant invers find amd risk risk variant counterin tuitiv complement activ general thought associ increas inflamma tion prime activ microglia expect associ faster diseas progress hand sever demonstr low plos pone progress geograph atrophi lesion amd level inflamm benefici knockout mice implic compl ment system neurogenesi show increas level complement activ promot neurogenesi healthi diseas neuron tissu presenc immun cell low level complement activ reveal neuroprotect properti pro perdin regul altern complement pathway protect inflammatori diseas shed light complement activa tion neurodegen inflammatori diseas take find account activ neurogenesi neuroprotect increas complement activ coun teract neurodegen activ reduc lesion growth replic earlier report influenc diseas status fellow eye lesion growth slope size bilater virtual cohort analys correl depend variant creas risk progress earli late amd well growth rate lesion variant explain increas growth bilater patient pro mote onset fellow eye increas growth rate lesion ever multivari model variabl variant bilater show independ correl growth addit signific associ detect presenc bilater combin dataset orallel individu analys furthermor risk increas allel independ correl decreas progr sion rate find argu strong confound risk increas genet factor increas growth rate bilater patient specif risk creas allel reduc lesion growth signific associ serv risk allel presenc bilater orallel factor must influenc onset fellow eye plain increas growth rate bilater find reveal signific independ contribut genet factor presenc fellow eye lesion growth design evalu futur trial aim test proach factor great confound particular growth rate main parametr area growth rate lesion necessarili correl visual acuiti frequent phenomenon foveal spare period difficult draw data patient vision retain futur need evalu pact genet factor visual percept support inform allel frequenc evalu genet variant doc acknowledg thank patient control individu particip kerstin meier rgen kaschk institut human regensburg technic support famstudi group provid patient control support part deutsch forschungsgemeinschaft bhfw alcon institut bhfw eyc intramur programmem plos pone progress geograph atrophi lesion amd nation eye institut eyc grant nation eye institut tional institut bethesda mlk fam group ophthalmolog bonn frank holz steffen schmitzvalckenberg monika fleckenstein arno bel moritz lindner julia steinberg almut bindewald wittich joanna czauderna institut biostatist bonn rolf fimmer institut human regensburg bernhard weber ophthalmolog aachen walter andrea weinberg ophthalmolog inselspit bern switzerland sebastian wolf ute schnurrbusch wolf ophthalmolog heidelberg lcker friederik mackensen ophthalmolog leipzig wiedoemann andrea ssner ophthalmolog franziskus nster daniel pauleikhoff georg spital ophthalmolog rzburg claudia strachwitz contribut conceiv design experi bhfw fgh perform experi analys data ssv apg fgh eyc mlk contribut reagent materi tool eyc mlk wrote paper eyc ssv apg mlk fgh bhfw refer cheung cmg klein cheng global preval agerel macular degener diseas burden project systemat metaanalysi lancet glob heal pmid sallo peto leung xing bunc bird intern classif system progress agerel macular degener curr eye res pmid kinnunen petrovski moe berta kaarniranta mechan retin pig ment epithelium damag agerel macular degener acta ophthalmol pmid abdelsalam prior zarbin drusen agerel macular degener pathogen sis natur cours laser photocoagulationinduc regress surv ophthalmol pmid lim mitchel seddon holz agerel macular degener lancet pmid schmidterfurth chong loewenstein larsen soui schlingemann guid line manag neovascular agerel macular degener european societi retina specialist euretina ophthalmol bjophthalmol pmid augood vingerl jong ptvm chakravarthi seland soubran preva lenc agerel maculopathi older european european eye eurey arch ophthalmol pmid plos pone progress geograph atrophi lesion amd klein klein bek knudtson meuer swift gangnon fifteenyear cumul cidenc agerel macular degener beaver dam eye ophthalmolog pmid lindblad lloyd clemon gensler ferri klein chang area geograph atrophi agerel eye diseas are report number arch ophthal mol archophthalmol pmid klein ferri franci lindblad chew hamon progress geo graphic atrophi genotyp agerel macular degener ophthalmolog ophtha pmid fleckenstein adrion schmitzvalckenberg bel bindewaldwittich scholl hpn concord diseas progress bilater geograph atrophi amd invest ophthalmol vis sci iov pmid fleckenstein schmitzvalckenberg adrion visvalingam bel ssner progress agerel geograph atrophi role fellow eye invest ophthalmol vis sci iov pmid sun gonzalezbaron appleg bressler tian hawkin enlarg ment atrophi visual acuiti loss geograph atrophi form agerel macular degenera tion ophthalmolog pmid fritsch chen schu yaspan thorleifsson loci associat agerel macular degener nat genet pmid fritsch fariss stambolian abecasi curcio swaroop agerel macu lar degener come annu rev genom hum genet annurev pmid scholl hpn fleckenstein fritsch schmitzvalckenberg bel adrion cfh signific risk loci suscept diseas progress geo graphic atrophi amd plos pone pmid cair recald velazquezvilloria garciagarcia reiter anter growth geograph atrophi fundus autofluoresc polymorph cfh cfb agerel macular degener jama ophthalmol feuer yehoshua gregori penha chew ferri squar root transfor mation geograph atrophi area measur elimin depend growth rate baselin lesion measur reanalysi agerel eye diseas report jama ophthalmol jamaophthalmol pmid dreyhaupt mansmann pritsch dolarszczasni bindewald holz model natur historey geograph atrophi patient agerel macular degener ophthalm epidemiol pmid holz bindewaldwittich fleckenstein dreyhaupt scholl hpn schmitzvalckenberg progress geograph atrophi fundus autofluoresc pattern agerelat macular degener ophthalmol pmid grassmann fritsch keilhauer heid weber bhf model genet risk agerel macular degener plos pone pmid wickham eleg graphic data core team languag environ statist comput viechtbauer conduct metaanalys metafor packag stat softw klein meuer knudtson klein bek epidemiolog progress pure geo graphic atrophi beaver dam eye ophthalmol ajo pmid sun margalit srikumaran appleg tian perri longterm nat ural historey geograph atrophi agerel macular degener enlarg atrophi implic intervent trial ophthalmolog pmid seddon reynold rosner genet loci cfh variant independ relat progress advanc macular degener plos pone pmid plos pone progress geograph atrophi lesion amd klein franci ferri hamon clemon risk assess model develop ment advanc agerel macular degener arch ophthalmol archophthalmol pmid fritsch fleckenstein fiebig schmitzvalckenberg bindewaldwittich keilhauer subgroup agerel macular degener associ monoallel sequenc variant invest ophthalmol vis sci iov pmid smailhodz fleckenstein theelen boon cjf huet rac ven jph central areolar choroid dystrophi cacd agerel macular degener amd differentiat ing characterist multimod imag invest ophthalmol vis sci iov pmid fritsch loenhardt janssen fisher rivera keilhauer agerel macular degener associ unstabl mrna nat genet pmid friedrich myer fritsch milenkovich wolf corbo risk nonrisk associ variant amd locus influenc mrna express patho genic effect protein defici hum mol genet hmg pmid heurich mart nez barricart franci robert rodr guez rdoba morgan common polymorph collabour determin system compl ment activ diseas risk proc natl acad sci pnas pmid ramaglia hugh donev ruseva huitinga mecha nism microgli prime relev multipl sclerosi proc natl acad sci pnas pmid griffith neal fontain gasqu complement marker self pro tect autoimmun encephalomyel immunol jimmunol pmid rahpeymai hietala wilhelmsson fotheringham davi nilsson plement basal ischemiainduc neurogenesi embo pmid beek nicol ali ischenko mackenzi buisson complement anaphi latoxin select protect nmdainduc neuron death neuroreport pmid steiner francescut byrn hugh jayanthi guschina protect role pro perdin progress murin atherosclerosi plos pone pmid steiner wolf kempermann adult neurogenesi neurodegen diseas regen pmid pekni wilhelmsson bogest pekna role astrocyt complement sys neural plastic int rev neurobiol pmid klein franci rosner reynold hamon schultz cfh genotyp antioxid zinc agerel macular generat ophthalmolog ophtha pmid plos pone